UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 356

Sortiert nach

Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants

Progress in neuro-psychopharmacology & biological psychiatry, 2013-10, Vol.46, p.224-235

2013

Volltextzugriff (PDF)

A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it

The journal of clinical psychiatry, 2011-05, Vol.72 (5), p.589

2011

Volltextzugriff (PDF)

Comparative efficacy and acceptability of pharmacological interventions for the treatment and prevention of delirium: A systematic review and network meta-analysis

Journal of psychiatric research, 2020-06, Vol.125, p.164-176

2020

Volltextzugriff (PDF)

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise

Current neuropharmacology, 2009-12, Vol.7 (4), p.331-336

2009

Volltextzugriff (PDF)

Investigating the effectiveness of a smart mental health intervention (inMind) for stress reduction during pharmacological treatment for mild to moderate major depressive disorders: Study protocol for a randomized control trial

Frontiers in psychiatry, 2023-03, Vol.14, p.1034246-1034246

2023

Volltextzugriff (PDF)

A review of current evidence for acetyl- l -carnitine in the treatment of depression

Journal of psychiatric research, 2014-06, Vol.53, p.30-37

2014

Volltextzugriff (PDF)

Aripiprazole as Adjunctive Therapy for Patients with Major Depressive Disorder: Overview and Implications of Clinical Trial Data

CNS drugs, 2011-02, Vol.25 (2), p.109-127

2011

Volltextzugriff (PDF)

A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders

PloS one, 2017-06, Vol.12 (6), p.e0179247-e0179247

2017

Volltextzugriff (PDF)

Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-based Care for the Treatment of Major Depressive Disorder

CNS drugs, 2013-05, Vol.27 (Suppl 1), p.29-37

2013

Volltextzugriff (PDF)

Modafinil for the treatment of Attention-deficit/hyperactivity disorder: a meta-analysis

Journal of psychiatric research, 2017-01, Vol.84, p.292-300

2017

Volltextzugriff (PDF)

A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection

Hepatology (Baltimore, Md.), 2020-06, Vol.71 (6), p.1894-1909

2020

Volltextzugriff (PDF)

Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder

Journal of psychiatry & neuroscience, 2015-05, Vol.40 (3), p.174-186

2015

Volltextzugriff (PDF)

Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?

Clinical Psychopharmacology and Neuroscience, 2021, 19(3), , pp.434-448

2021

Volltextzugriff (PDF)

Effect of Frailty on Depression among Patients with Late-life Depression: A Test of Anger, Anxiety, and Resilience as Mediators

Clinical Psychopharmacology and Neuroscience, 2024, 22(2), , pp.253-262

2024

Volltextzugriff (PDF)

Preclinical pharmacology of amphetamine: Implications for the treatment of neuropsychiatric disorders

Pharmacology & therapeutics (Oxford), 2014-09, Vol.143 (3), p.253-264

2014

Volltextzugriff (PDF)

Sensitivity of cognitive tests in four cognitive domains in discriminating MDD patients from healthy controls: a meta-analysis

International psychogeriatrics, 2013-09, Vol.25 (9), p.1543-1557

2013

Volltextzugriff (PDF)

Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: A systematic review and meta-analysis

Journal of psychiatric research, 2015-05, Vol.64, p.88-98

2015

Volltextzugriff (PDF)

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study

PSYCHIATRY INVESTIGATION, 2022, 19(4), , pp.268-280

2022

Volltextzugriff (PDF)

The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting

Clinical Psychopharmacology and Neuroscience, 2024, 22(2), , pp.370-375

2024

Volltextzugriff (PDF)

Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature

Journal of addictive diseases, 2020-02, Vol.38 (2), p.186-199

2020

Volltextzugriff (PDF)

Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting

Clinical Psychopharmacology and Neuroscience, 2023, 21(3), , pp.594-598

2023

Volltextzugriff (PDF)

Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression

Journal of affective disorders, 2019-04, Vol.249, p.410-417

2019

Volltextzugriff (PDF)

Non-prescribed use of pain relievers among adolescents in the United States

Drug and alcohol dependence, 2008-04, Vol.94 (1), p.1-11

2008

Volltextzugriff (PDF)

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study

Psychiatry investigation, 2022-06, Vol.19 (6), p.500-500

2022

Volltextzugriff (PDF)

Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2023-02, Vol.21 (1), p.135-146

2023

Volltextzugriff (PDF)

1 – 25 von 356

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(335)
Mit Volltextzugriff
(297)

Publikationsform

Sprache

Englisch
(332)
Koreanisch
(24)
Japanisch
(17)

Erscheinungsjahr

n.n

Thema

Science & Technology
(260)
Life Sciences & Biomedicine
(251)
Humans
(214)
Psychiatry
(133)
Female
(129)
Male
(128)
Adult
(116)
Pharmacology & Pharmacy
(95)
Neurosciences & Neurology
(90)
Biological And Medical Sciences
(84)
Medical Sciences
(84)
Middle Aged
(69)
Psychology. Psychoanalysis. Psychiatry
(69)
Psychopathology. Psychiatry
(66)
Neurosciences
(64)
Treatment Outcome
(62)
Adult And Adolescent Clinical Studies
(60)
Clinical Neurology
(53)
Substance Abuse
(51)
Depression
(48)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants

A national epidemic of unintentional prescription opioid overdose deaths: how physicians can help control it

Comparative efficacy and acceptability of pharmacological interventions for the treatment and prevention of delirium: A systematic review and network meta-analysis

Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise

Investigating the effectiveness of a smart mental health intervention (inMind) for stress reduction during pharmacological treatment for mild to moderate major depressive disorders: Study protocol for a randomized control trial

A review of current evidence for acetyl- l -carnitine in the treatment of depression

Aripiprazole as Adjunctive Therapy for Patients with Major Depressive Disorder: Overview and Implications of Clinical Trial Data

A Korean validation study of the Clinically Useful Anxiety Outcome Scale: Comorbidity and differentiation of anxiety and depressive disorders

Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-based Care for the Treatment of Major Depressive Disorder

Modafinil for the treatment of Attention-deficit/hyperactivity disorder: a meta-analysis

A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection

Vortioxetine: a meta-analysis of 12 short-term, randomized, placebo-controlled clinical trials for the treatment of major depressive disorder

Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?

Effect of Frailty on Depression among Patients with Late-life Depression: A Test of Anger, Anxiety, and Resilience as Mediators

Preclinical pharmacology of amphetamine: Implications for the treatment of neuropsychiatric disorders

Sensitivity of cognitive tests in four cognitive domains in discriminating MDD patients from healthy controls: a meta-analysis

Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: A systematic review and meta-analysis

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study

The Potential Role of Aripiprazole Augmentation for Major Depressive Disorder with Anxious Distress in Naturalistic Treatment Setting

Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature

Additional Clinical Benefit of Agomelatine Treatment for Major Depressive Disorder in Naturalistic Treatment Setting

Reduced CXCL1/GRO chemokine plasma levels are a possible biomarker of elderly depression

Non-prescribed use of pain relievers among adolescents in the United States

Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study

Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial

Suchergebnisse filtern